Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood
- PMID: 33992435
- PMCID: PMC9063977
- DOI: 10.1016/j.vaccine.2021.04.019
Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood
Abstract
Purpose: Young adulthood is characterized by changes in health care decision-making, insurance coverage, and sexual risk. Although the human papillomavirus (HPV) vaccine is now approved for adults up to age 45, and catch-up vaccination is currently recommended up through age 26, vaccination rates remain low in young adults. This study explored perspectives on HPV vaccination among young adults receiving care at the student health center of a large public university.
Methods: We conducted semi-structured interviews (n = 27) and four focus groups with female and male undergraduate and graduate students (n = 18) and semi-structured interviews with health care providers (n = 6). Interviews and focus groups explored perceived risk of HPV infection, benefits of the HPV vaccine, and motivations for and barriers to HPV vaccination.
Results: Many young adults cited their parents' views and recommendations from medical providers as influential on their decision-making process. Students perceived that cervical cancer prevention was a main benefit of the HPV vaccine and sexual activity was a risk factor for HPV infection. Students often lacked knowledge about the vaccine's benefits for males and expressed some concerns about the safety and side effects of a vaccine perceived as new. Logistical barriers to vaccination included uncertainty over vaccination status and insurance coverage for the vaccine, and concerns about balancing the vaccine schedule with school obligations. Providers' vaccine recommendations were impacted by health system factors, including clinical infrastructure, processes for recommending and documenting vaccination, and office visit priorities. Suggested vaccination promotion strategies included improving the timing and messaging of outreach efforts on campus and bolstering clinical infrastructure.
Conclusions: Although college may be an opportune time to reach young adults for HPV vaccination, obstacles including navigating parental influence and independent decision-making, lack of awareness of vaccination status, and numerous logistical and system-level barriers may impede vaccination during this time.
Keywords: College health, health behavior; HPV vaccine; Human papillomavirus; Sexual health; Vaccination.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.BMC Public Health. 2020 Dec 1;20(1):1836. doi: 10.1186/s12889-020-09962-1. BMC Public Health. 2020. PMID: 33256697 Free PMC article.
-
Knowledge, attitudes, and practices related to human papillomavirus vaccination among college students in a state university: Implications for nurse practitioners.J Am Assoc Nurse Pract. 2020 Jun 23;33(9):709-718. doi: 10.1097/JXX.0000000000000431. J Am Assoc Nurse Pract. 2020. PMID: 32590447
-
Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.Vaccine. 2019 Sep 24;37(41):6030-6038. doi: 10.1016/j.vaccine.2019.08.053. Epub 2019 Aug 28. Vaccine. 2019. PMID: 31473002
-
Application of the theoretical domains framework to identify factors influencing catch-up HPV vaccinations among male college students in the United States: A review of evidence and recommendations.Vaccine. 2023 May 26;41(23):3564-3576. doi: 10.1016/j.vaccine.2023.04.071. Epub 2023 May 8. Vaccine. 2023. PMID: 37164820 Review.
-
Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.Sex Transm Dis. 2021 Dec 1;48(12):e255-e262. doi: 10.1097/OLQ.0000000000001407. Sex Transm Dis. 2021. PMID: 33783412 Free PMC article.
Cited by
-
Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis.PLoS One. 2025 May 5;20(5):e0321448. doi: 10.1371/journal.pone.0321448. eCollection 2025. PLoS One. 2025. PMID: 40323965 Free PMC article.
-
Gender-neutral vs. gender-specific strategies in school-based HPV vaccination programs: a systematic review and meta-analysis.Front Public Health. 2025 Feb 18;13:1460511. doi: 10.3389/fpubh.2025.1460511. eCollection 2025. Front Public Health. 2025. PMID: 40041177 Free PMC article.
-
Improving United States HPV vaccination rates: Factors predictive of parental attitudes towards middle school entry requirements.Hum Vaccin Immunother. 2024 Dec 31;20(1):2390231. doi: 10.1080/21645515.2024.2390231. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39268680 Free PMC article.
-
Association between Religious Beliefs and HPV Vaccination Attitudes among College Students.Vaccines (Basel). 2023 Oct 21;11(10):1623. doi: 10.3390/vaccines11101623. Vaccines (Basel). 2023. PMID: 37897025 Free PMC article.
-
Human Papillomavirus Vaccination Uptake and Its Predictors Among Female Adolescents in Gulu Municipality, Northern Uganda.Adolesc Health Med Ther. 2022 Sep 25;13:77-91. doi: 10.2147/AHMT.S383872. eCollection 2022. Adolesc Health Med Ther. 2022. PMID: 36186270 Free PMC article.
References
-
- Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sexually transmitted diseases. Mar 2013;40(3):187–193. - PubMed
-
- Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States. Atlanta, GA: Centers for Disease Control and Prevention;2013.
-
- National Cancer Institute. HPV and Cancer. 2015; http://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-age....
-
- Boersma P, Black L. Human Papillomavirus Vaccination Among Adults Aged 18–26, 2013–2018. NCHS Data Brief, no 354. Hyattsville, MD: National Center for Health Statistics;2020. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical